3.9200
+1.3800
+(54.33%)
At close: January 31 at 4:00:01 PM EST
4.1207
+0.20
+(5.12%)
After hours: 7:59:55 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 551.05k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SLATE PATH CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.55 per share. | Indirect | 555,108 | Nov 21, 2024 |
| HECHT PETER M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| GRAUL REGINA MARGARET President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 29, 2023 |
| HECHT PETER M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 1, 2023 |
| DESOUZA ERROL B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2023 |
| HYMAN STEVEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2023 |
| MCGUIRE TERRANCE G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2023 |
| MCGUIRE TERRANCE G Director | Sale at price 3.40 per share. | Indirect | 27 | Aug 9, 2023 |
| HECHT PETER M Chief Executive Officer | Stock Award(Grant) at price 5.26 per share. | Direct | 1,183,500 | May 19, 2023 |
Related Tickers
NLSP NLS Pharmaceutics AG
2.4900
+25.76%
ATNF 180 Life Sciences Corp.
1.4000
-2.78%
PLRZ Polyrizon Ltd.
1.1500
-12.88%
DOMH Dominari Holdings Inc.
3.4900
-2.51%
THAR Tharimmune, Inc.
1.9600
+0.51%
PBM Psyence Biomedical Ltd.
1.5700
-3.09%
CARM Carisma Therapeutics, Inc.
0.4598
-7.86%
EDSA Edesa Biotech, Inc.
1.9050
+0.79%
PRTG Portage Biotech Inc.
4.4100
-3.29%
DRMA Dermata Therapeutics, Inc.
1.2300
+2.50%